miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α

Resistance to chemotherapy is a primary problem for the effective treatment of ovarian cancer. Recently, increasing evidence has demonstrated that miRNAs modulate many important molecular pathways involved in chemotherapy. Previous studies demonstrated that miR-199a affected ovarian cancer cell resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xue, Liu, Ning, Deng, Suo, Zhang, Dandan, Wang, Kexin, Lu, Meisong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731338/
https://www.ncbi.nlm.nih.gov/pubmed/29276393
http://dx.doi.org/10.2147/OTT.S145833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731338/
https://www.ncbi.nlm.nih.gov/pubmed/29276393
http://dx.doi.org/10.2147/OTT.S145833

Ejemplares similares